PedchenkoV., BondarO., FogoA.B.. Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis.New Eng J Med2010; 363(4): 343–54.
3.
KleppelM.M., SantiP.A., CameronJ.D., WieslanderJ., MichealA.F.. Human tissue distribution of novel basement membrane collagen.Am J Pathol1989; 134: 813–25.
4.
CashmanS., PuseyC., EvansD.. Extraglomerular distribution of immunoreactive Goodpasture antigen.J Pathol1988; 155: 61–70.
5.
ZouJ., HannierS., CairnsL.S., BarkerR.N., ReesA.J., TurnerA.N., PhelpsR.G.. Healthy individuals have Goodpasture autoantigen-reactive cells.J Am Soc Nephrol2008; 19: 396–404.
6.
WongD., PhelpsR.G., TurnerA.N.. The Goodpasture antigen is expressed in the human thymus.Kid Int2001; 60: 1777–83.
7.
SalamaA.D., ChaudhryA.N., RyanJ.J.. In Goodpasture's disease, CD4+ T cells escape thymic deletion and are reactive with the autoantigen α3(I)NC1.J Am Soc Nephrol2001; 12: 1908–15.
8.
NossalG.J.. Negative selection of lymphocytes.Cell1994; 76: 229–39.
9.
HudsonB.G., TryggvasonK., SundaramoorthyM., NeilsonE.. Alport's syndrome, Goodpasture syndrome and type IV collagen.New Engl J Med2003; 348(25): 2543–56.
SinicoR.A., RadiceA., CoraceC., SabadiniE., BolliniB.. Anti-glomerular membrane basement antibodies in the diagnosis of Goodpasture's syndrome: a comparison of different assays.Nephrol Dial Transplant2006; 21: 397–401.
13.
SalamaA.D., DouganT., LevyJ.B.. Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques.Am J Kidney Dis2002; 39: 1162–7.
